The NAD+ 1000mg & Retatrutide: The UK Innovation in Metabolic Wellbeing
Emerging research from the UK are generating considerable interest surrounding the potential combination of high-dose NAD+ supplementation (1000mg) and the novel GLP-1 receptor agonist, Retatrutide. This unusual approach aims to target multiple facets of metabolic imbalance , potentially offering